Comments
Strides Pharma Science on Tuesday informed the exchanges that the company’s formulations facility (KRSG Gardens) in Bangalore has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration. The facility was inspected by the USFDA in May 2019, thereby confirming the successful closure of the inspection. The stock of Strides Pharma slumped 1.90 per cent at ₹343.30 on the BSE
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.